Ishibashi Kazuya, Osamura Tomoko, Shiraishi Hirokazu, Shirayama Takeshi, Yamahara Yasuhiro, Matsubara Hiroaki
Department of Cardiology, Saiseikai Kyoto Hospital, Kyoto, Japan.
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine, Kyoto, Japan.
J Cardiol Cases. 2009 Nov 8;1(1):e56-e62. doi: 10.1016/j.jccase.2009.07.004. eCollection 2010 Feb.
We report a case of idiopathic dilated cardiomyopathy with severe heart failure and complete left bundle branch block (CLBBB) which exhibited an excellent response to cardiac resynchronization therapy (CRT). A 71-year-old male had been treated for 9 years with medication for chronic heart failure. He was referred to hospital with a complaint of dyspnea. An electrocardiogram showed CLBBB, with a QRS-width of 200 ms. Markedly dilated left ventricular (LV) chamber with a low ejection fraction (EF) of 18% and severe mitral regurgitation were registered by echocardiogram. Myocardial neuronal I-metaiodobenzylguanidine uptake was reduced, with a heart-to-mediastinum (H/M) ratio of 1.88. Immediately after the introduction of CRT, clinical improvement was observed. At 1-year follow-up, LV chamber size and cardiac function were almost normalized, with an EF of 53%. Cardiac sympathetic nerve activity (CSNA) was simultaneously normalized, with an H/M ratio of 2.32 and a washout rate of 14.7%. However, after the cessation of carvedilol administration, CSNA and LV systolic function were slightly aggravated, with an H/M ratio of 2.20, a washout rate of 15.9%, and an EF of 44%. In the present case, the excellent improvement in cardiac function and CSNA was caused by the combined effects of beta-blocker therapy and CRT.
我们报告一例患有严重心力衰竭和完全性左束支传导阻滞(CLBBB)的特发性扩张型心肌病患者,该患者对心脏再同步治疗(CRT)表现出极佳的反应。一名71岁男性因慢性心力衰竭接受药物治疗已9年。他因呼吸困难前来就诊。心电图显示CLBBB,QRS波宽度为200毫秒。超声心动图显示左心室(LV)腔明显扩张,射血分数(EF)低至18%,并伴有严重二尖瓣反流。心肌神经元I-间碘苄胍摄取减少,心/纵隔(H/M)比值为1.88。在引入CRT后立即观察到临床改善。在1年的随访中,左心室腔大小和心脏功能几乎恢复正常,EF为53%。心脏交感神经活动(CSNA)同时恢复正常,H/M比值为2.32,洗脱率为14.7%。然而,在停用卡维地洛后,CSNA和左心室收缩功能略有加重,H/M比值为2.20,洗脱率为15.9%,EF为44%。在本病例中,心脏功能和CSNA的极佳改善是由β受体阻滞剂治疗和CRT的联合作用所致。